**
Recent research from Mount Sinai has unveiled a concerning reality regarding the exposure of fetuses to per- and polyfluoroalkyl substances (PFAS), commonly known as “forever chemicals.” A comprehensive analysis of umbilical cord blood indicates that unborn babies may be inundated with significantly higher levels of these hazardous compounds than previously recognised.
Unprecedented Findings in Umbilical Cord Blood
Traditionally, studies focusing on PFAS in umbilical cord blood have concentrated on a limited number of compounds, primarily PFOA and PFOS. However, the latest investigation utilised an advanced “non-targeted analysis” approach on 120 umbilical cord blood samples, previously noted to contain only a handful of these substances. This new methodology identified a staggering 42 distinct PFAS compounds across the samples, revealing that the total concentration of these chemicals was far greater than earlier estimates.
Shelley Liu, a co-author of the study and associate professor at the Icahn School of Medicine at Mount Sinai, emphasised the significance of these findings, stating, “It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.” This research highlights the urgent need to comprehend the full scope of PFAS exposure during pregnancy.
The Health Implications of PFAS Exposure
PFAS consists of a vast array of around 15,000 chemicals, commonly employed to impart water, stain, and grease resistance to various products. Unfortunately, these substances have also been linked to a plethora of serious health issues, including cancer, birth defects, immune system dysfunction, and cardiovascular disease. Their moniker, “forever chemicals,” stems from their resistance to natural degradation in the environment, raising concerns about their persistence and potential accumulation in human systems.
A review encompassing 40 studies has confirmed the pervasive presence of PFAS in umbilical cord blood, with researchers detecting these substances in every one of the 30,000 samples analysed. Notably, elevated levels of PFAS in mothers have been correlated with increased risks of infant mortality, low birth weight, and obesity in later life. Furthermore, fetal exposure has been linked to long-term health consequences, including cancer and neurological disorders.
Regulatory Challenges and Gaps in Detection
The transition from older PFAS compounds like PFOA and PFOS to newer generations—often marketed as less toxic—has outpaced regulatory measures. While the US Environmental Protection Agency (EPA) has begun recognising and testing for 53 PFAS compounds, their methods have not kept pace with the evolving landscape of these chemicals. The EPA’s testing typically focuses on a mere 30-40 compounds, despite independent research revealing thousands of PFAS in various environments.
Mount Sinai’s innovative study effectively juxtaposed traditional testing methods against the newly adopted non-targeted analysis, which uncovered a broader spectrum of PFAS. While the EPA’s recent enhancements are a step forward, Liu noted that their testing still missed 31 compounds identified in this study, underscoring the inadequacies in current regulatory frameworks.
A Call for Action
Though the Mount Sinai study did not directly investigate the health repercussions of heightened PFAS levels in fetal blood, Liu acknowledged that increased concentrations are generally associated with greater health risks. The samples were part of the federal government’s Home study—a long-term investigation tracking PFAS exposure and subsequent health outcomes.
David Andrews, acting chief science officer with the Environmental Working Group, which was not involved in the research, remarked, “This paper is a stark reminder of the importance of health-protective regulations and how lax oversight can result in babies being born pre-polluted with harmful chemicals such as PFAS.” The findings illuminate a pressing need for health-protective regulations to safeguard both mothers and their unborn children from the dangers posed by these persistent chemicals.
Why it Matters
The implications of this research extend far beyond scientific curiosity; they underscore a critical public health concern. As our understanding of PFAS exposure deepens, it becomes increasingly clear that regulatory bodies must prioritise stringent measures to protect vulnerable populations, particularly pregnant women and their developing offspring. The evidence is mounting—without decisive action to limit and monitor PFAS exposure, we risk perpetuating a cycle of health crises that could affect generations to come.